623 related articles for article (PubMed ID: 32348641)
21. [Chronic inflammatory bowel disease and COVID-19].
Moum B
Tidsskr Nor Laegeforen; 2020 May; 140(7):. PubMed ID: 32378846
[No Abstract] [Full Text] [Related]
22. Psoriasis-COVID 19 Infection: Treatment Options.
Tampouratzi E; Kanni T; Katsantonis J; Douvali T
Skinmed; 2020; 18(2):81-82. PubMed ID: 32501789
[No Abstract] [Full Text] [Related]
23. Non-complicated evolution of COVID-19 infection in a patient with psoriasis and psoriatic arthritis during treatment with adalimumab.
Valenti M; Facheris P; Pavia G; Gargiulo L; Borroni RG; Costanzo A; Narcisi A
Dermatol Ther; 2020 Jul; 33(4):e13708. PubMed ID: 32474988
[No Abstract] [Full Text] [Related]
24. The allergist/immunologist, the Janus gatekeeper of inflammation, COVID-19 and beyond.
Bellanti JA; Settipane RA
Allergy Asthma Proc; 2020 Nov; 41(6):395-396. PubMed ID: 33109305
[No Abstract] [Full Text] [Related]
25. The use of Janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Peterson D; Damsky W; King B
J Am Acad Dermatol; 2020 Jun; 82(6):e223-e226. PubMed ID: 32278797
[No Abstract] [Full Text] [Related]
26. Young Children Presenting With Fever and Rash in the Midst of SARS-CoV-2 Outbreak in New York.
Wolfe DM; Nassar GN; Divya K; Krilov LR; Noor A
Clin Pediatr (Phila); 2020 Oct; 59(12):1112-1118. PubMed ID: 32633553
[No Abstract] [Full Text] [Related]
27. Olfactory and Gustatory Dysfunction in a COVID-19 Patient with Ankylosing Spondylitis Treated with Etanercept: Case Report.
Lee JM; Lee SJ
J Korean Med Sci; 2020 Jun; 35(21):e201. PubMed ID: 32476306
[TBL] [Abstract][Full Text] [Related]
28. A Case Series of the 2019 Novel Coronavirus (SARS-CoV-2) in 3 Febrile Infants in New York.
Feld L; Belfer J; Kabra R; Goenka P; Rai S; Moriarty S; Barone S
Pediatrics; 2020 Jul; 146(1):. PubMed ID: 32404431
[TBL] [Abstract][Full Text] [Related]
29. COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management.
Mugheddu C; Pizzatti L; Sanna S; Atzori L; Rongioletti F
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e376-e378. PubMed ID: 32385859
[No Abstract] [Full Text] [Related]
30. Reply to: "COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution".
Lebwohl M; Rivera-Oyola R; Murrell DF
J Am Acad Dermatol; 2020 Jun; 82(6):e215. PubMed ID: 32283232
[No Abstract] [Full Text] [Related]
31. Psoriasis and psoriatic arthritis: How to manage immunosuppressants in COVID-19 days.
Coletto LA; Favalli EG; Caporali R
Dermatol Ther; 2020 Jul; 33(4):e13415. PubMed ID: 32291828
[No Abstract] [Full Text] [Related]
32. [A gastrointestinal overview of COVID-19].
Konturek PC
MMW Fortschr Med; 2020 Apr; 162(8):59-60. PubMed ID: 32342369
[TBL] [Abstract][Full Text] [Related]
33. Severe immune thrombocytopenia in a critically ill COVID-19 patient.
Martincic Z; Skopec B; Rener K; Mavric M; Vovko T; Jereb M; Lukic M
Int J Infect Dis; 2020 Oct; 99():269-271. PubMed ID: 32771636
[TBL] [Abstract][Full Text] [Related]
34. [Biological therapy after COVID-19 infection : No reactivation of a COVID-19 infection with positive SARS-CoV-2 antibody status under biological therapy].
Steinchen N; Müller-Ladner U; Lange U
Z Rheumatol; 2020 Aug; 79(6):574-577. PubMed ID: 32514854
[TBL] [Abstract][Full Text] [Related]
35. Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.
Monti S; Balduzzi S; Delvino P; Bellis E; Quadrelli VS; Montecucco C
Ann Rheum Dis; 2020 May; 79(5):667-668. PubMed ID: 32241793
[No Abstract] [Full Text] [Related]
36. SARS-CoV-2 infection among patients with systemic autoimmune diseases.
Emmi G; Bettiol A; Mattioli I; Silvestri E; Di Scala G; Urban ML; Vaglio A; Prisco D
Autoimmun Rev; 2020 Jul; 19(7):102575. PubMed ID: 32376395
[TBL] [Abstract][Full Text] [Related]
37. Guillain-Barré Syndrome Associated with SARS-CoV-2.
Toscano G; Palmerini F; Ravaglia S; Ruiz L; Invernizzi P; Cuzzoni MG; Franciotta D; Baldanti F; Daturi R; Postorino P; Cavallini A; Micieli G
N Engl J Med; 2020 Jun; 382(26):2574-2576. PubMed ID: 32302082
[No Abstract] [Full Text] [Related]
38. Small bowel ischemia and SARS-CoV-2 infection: an underdiagnosed distinct clinical entity.
Ignat M; Philouze G; Aussenac-Belle L; Faucher V; Collange O; Mutter D; Pessaux P
Surgery; 2020 Jul; 168(1):14-16. PubMed ID: 32473831
[No Abstract] [Full Text] [Related]
39. SARS CoV-2 infection among patients using immunomodulatory therapies.
Winthrop KL; Brunton AE; Beekmann S; Polgreen P; Baddley J; Saag KG; Calabrese C; Calabrese L; Robinson PC; Wallace ZS; Curtis JR;
Ann Rheum Dis; 2021 Feb; 80(2):269-271. PubMed ID: 32759259
[No Abstract] [Full Text] [Related]
40. Fatal Pulmonary Thromboembolism in SARS-CoV-2-Infection.
Grimes Z; Bryce C; Sordillo EM; Gordon RE; Reidy J; Paniz Mondolfi AE; Fowkes M
Cardiovasc Pathol; 2020; 48():107227. PubMed ID: 32718733
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
